A citation-based method for searching scientific literature

L J Roberts, K P Moore, W E Zackert, J A Oates, J D Morrow. J Biol Chem 1996
Times Cited: 122







List of co-cited articles
943 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.
J D Morrow, K E Hill, R F Burk, T M Nammour, K F Badr, L J Roberts. Proc Natl Acad Sci U S A 1990
68

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage.
J D Morrow, B Frei, A W Longmire, J M Gaziano, S M Lynch, Y Shyr, W E Strauss, J A Oates, L J Roberts. N Engl J Med 1995
42

Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
J D Morrow, W E Zackert, J P Yang, E H Kurhts, D Callewaert, R Dworski, K Kanai, D Taber, K Moore, J A Oates,[...]. Anal Biochem 1999
136
39


Non-cyclooxygenase-derived prostanoids (F2-isoprostanes) are formed in situ on phospholipids.
J D Morrow, J A Awad, H J Boss, I A Blair, L J Roberts. Proc Natl Acad Sci U S A 1992
580
36


Identification and measurement of endogenous beta-oxidation metabolites of 8-epi-Prostaglandin F2alpha.
C Chiabrando, A Valagussa, C Rivalta, T Durand, A Guy, E Zuccato, P Villa, J C Rossi, R Fanelli. J Biol Chem 1999
80
43

Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
Z Wang, G Ciabattoni, C Créminon, J Lawson, G A Fitzgerald, C Patrono, J Maclouf. J Pharmacol Exp Ther 1995
307
31


A nomenclature system for the isoprostanes.
D F Taber, J D Morrow, L J Roberts. Prostaglandins 1997
145
28

IPF2alpha-I: an index of lipid peroxidation in humans.
D Praticò, O P Barry, J A Lawson, M Adiyaman, S W Hwang, S P Khanapure, L Iuliano, J Rokach, G A FitzGerald. Proc Natl Acad Sci U S A 1998
186
27

Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine.
H Li, J A Lawson, M Reilly, M Adiyaman, S W Hwang, J Rokach, G A FitzGerald. Proc Natl Acad Sci U S A 1999
144
27

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid.
L J Roberts, T J Montine, W R Markesbery, A R Tapper, P Hardy, S Chemtob, W D Dettbarn, J D Morrow. J Biol Chem 1998
300
26

Modulation of oxidant stress in vivo in chronic cigarette smokers.
M Reilly, N Delanty, J A Lawson, G A FitzGerald. Circulation 1996
485
25

In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation.
G Davì, G Ciabattoni, A Consoli, A Mezzetti, A Falco, S Santarone, E Pennese, E Vitacolonna, T Bucciarelli, F Costantini,[...]. Circulation 1999
595
24


Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
M B Kadiiska, B C Gladen, D D Baird, D Germolec, L B Graham, C E Parker, A Nyska, J T Wachsman, B N Ames, S Basu,[...]. Free Radic Biol Med 2005
485
22


Nomenclature of isoprostanes: a proposal.
J Rokach, S P Khanapure, S W Hwang, M Adiyaman, J A Lawson, G A FitzGerald. Prostaglandins 1997
114
21

Plasma 8-epi-PGF2 alpha levels are elevated in individuals with non-insulin dependent diabetes mellitus.
N K Gopaul, E E Anggård, A I Mallet, D J Betteridge, S P Wolff, J Nourooz-Zadeh. FEBS Lett 1995
329
21

Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice.
D Praticò, R K Tangirala, D J Rader, J Rokach, G A FitzGerald. Nat Med 1998
419
20

Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors.
K Takahashi, T M Nammour, M Fukunaga, J Ebert, J D Morrow, L J Roberts, R L Hoover, K F Badr. J Clin Invest 1992
462
20


Localization of distinct F2-isoprostanes in human atherosclerotic lesions.
D Praticò, L Iuliano, A Mauriello, L Spagnoli, J A Lawson, J Rokach, J Maclouf, F Violi, G A FitzGerald. J Clin Invest 1997
289
19



Free radical-induced generation of isoprostanes in vivo. Evidence for the formation of D-ring and E-ring isoprostanes.
J D Morrow, T A Minton, C R Mukundan, M D Campbell, W E Zackert, V C Daniel, K F Badr, I A Blair, L J Roberts. J Biol Chem 1994
240
19

Evidence for the formation of F3-isoprostanes during peroxidation of eicosapentaenoic acid.
J Nourooz-Zadeh, B Halliwell, E E Anggård. Biochem Biophys Res Commun 1997
67
28


In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia.
G Davi, P Alessandrini, A Mezzetti, G Minotti, T Bucciarelli, F Costantini, F Cipollone, G B Bon, G Ciabattoni, C Patrono. Arterioscler Thromb Vasc Biol 1997
313
18

Identification and relative quantitation of F2-isoprostane regioisomers formed in vivo in the rat.
R J Waugh, J D Morrow, L J Roberts, R C Murphy. Free Radic Biol Med 1997
102
18

Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma.
C M Stein, S B Tanner, J A Awad, L J Roberts, J D Morrow. Arthritis Rheum 1996
143
17


Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients.
P Montuschi, M Corradi, G Ciabattoni, J Nightingale, S A Kharitonov, P J Barnes. Am J Respir Crit Care Med 1999
377
17

Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions.
C Gniwotta, J D Morrow, L J Roberts, H Kühn. Arterioscler Thromb Vasc Biol 1997
153
17

2,3-Dinor-5,6-dihydro-15-F(2t)-isoprostane: a bioactive prostanoid metabolite.
X Hou, L J Roberts, D F Taber, J D Morrow, K Kanai, F Gobeil, M H Beauchamp, S G Bernier, G Lepage, D R Varma,[...]. Am J Physiol Regul Integr Comp Physiol 2001
40
42

Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry.
Yuanling Liang, Ping Wei, Russell W Duke, Peter D Reaven, S Mitchell Harman, Richard G Cutler, Christopher B Heward. Free Radic Biol Med 2003
83
20

8-epi PGF2 alpha generation during coronary reperfusion. A potential quantitative marker of oxidant stress in vivo.
N Delanty, M P Reilly, D Pratico, J A Lawson, J F McCarthy, A E Wood, S T Ohnishi, D J Fitzgerald, G A FitzGerald. Circulation 1997
239
16

Allergen-induced synthesis of F(2)-isoprostanes in atopic asthmatics. Evidence for oxidant stress.
R Dworski, J J Murray, L J Roberts, J A Oates, J D Morrow, L Fisher, J R Sheller. Am J Respir Crit Care Med 1999
98
16



Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers.
P Montuschi, J V Collins, G Ciabattoni, N Lazzeri, M Corradi, S A Kharitonov, P J Barnes. Am J Respir Crit Care Med 2000
389
16

Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress.
D Praticò, S Basili, M Vieri, C Cordova, F Violi, G A Fitzgerald. Am J Respir Crit Care Med 1998
198
15



Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine.
J A Lawson, H Li, J Rokach, M Adiyaman, S W Hwang, S P Khanapure, G A FitzGerald. J Biol Chem 1998
65
21

Nonenzymatic free radical-catalyzed generation of thromboxane-like compounds (isothromboxanes) in vivo.
J D Morrow, J A Awad, A Wu, W E Zackert, V C Daniel, L J Roberts. J Biol Chem 1996
90
15

Increased F2-isoprostanes in Alzheimer's disease: evidence for enhanced lipid peroxidation in vivo.
D Praticò, V MY Lee, J Q Trojanowski, J Rokach, G A Fitzgerald. FASEB J 1998
315
14

The isoprostanes: a perspective.
J Rokach, S P Khanapure, S W Hwang, M Adiyaman, J A Lawson, G A FitzGerald. Prostaglandins 1997
84
16

Alcohol-induced generation of lipid peroxidation products in humans.
E A Meagher, O P Barry, A Burke, M R Lucey, J A Lawson, J Rokach, G A FitzGerald. J Clin Invest 1999
176
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.